Boston Total Assets vs Cash Analysis

BSX Stock

USD 106.11 0.03 0.03%

Boston Scientific financial indicator trend analysis is way more than just evaluating Boston Scientific Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boston Scientific Corp is a good investment. Please check the relationship between Boston Scientific Total Assets and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Total Assets vs Cash

Total Assets vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boston Scientific Corp Total Assets account and Cash. At this time, the significance of the direction appears to have strong relationship.

The correlation between Boston Scientific's Total Assets and Cash is 0.6. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Cash in the same time period over historical financial statements of Boston Scientific Corp, assuming nothing else is changed. The correlation between historical values of Boston Scientific's Total Assets and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Boston Scientific Corp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Assets i.e., Boston Scientific's Total Assets and Cash go up and down completely randomly.

Correlation Coefficient

0.6

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Assets

Total assets refers to the total amount of Boston Scientific assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Boston Scientific Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Cash

Cash refers to the most liquid asset of Boston Scientific Corp, which is listed under current asset account on Boston Scientific Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Boston Scientific customers. The amounts must be unrestricted with restricted cash listed in a different Boston Scientific account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most indicators from Boston Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

At this time, Boston Scientific's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 781.3 M in 2025, whereas Sales General And Administrative To Revenue is likely to drop 0.29 in 2025.

	2022	2023	2024	2025 (projected)
Gross Profit	8.7B	9.9B	11.4B	11.9B
Total Revenue	12.7B	14.2B	16.4B	17.2B

Gross Profit Total Revenue

Boston Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.97	0.82	0.78	0.98	0.99	0.95	0.58	0.92	0.6	1.0	0.72	0.6	0.96	0.62	0.71	0.95	0.54	0.88	0.96	0.83	0.98	0.1	0.56	0.67	0.79
Short Long Term Debt Total	0.97		0.87	0.84	0.92	0.94	0.99	0.54	0.89	0.6	0.96	0.8	0.6	0.93	0.59	0.73	0.89	0.57	0.82	0.97	0.74	0.95	0.22	0.57	0.66	0.86
Other Current Liab	0.82	0.87		0.94	0.75	0.82	0.87	0.32	0.84	0.44	0.81	0.87	0.44	0.87	0.56	0.55	0.78	0.57	0.77	0.87	0.67	0.84	0.36	0.52	0.64	0.86
Total Current Liabilities	0.78	0.84	0.94		0.71	0.78	0.86	0.31	0.8	0.3	0.78	0.93	0.31	0.87	0.54	0.45	0.78	0.49	0.73	0.83	0.67	0.78	0.62	0.52	0.6	0.9
Total Stockholder Equity	0.98	0.92	0.75	0.71		0.98	0.9	0.7	0.93	0.62	0.98	0.62	0.62	0.91	0.52	0.63	0.95	0.52	0.8	0.88	0.86	0.95	0.02	0.42	0.55	0.77
Property Plant And Equipment Net	0.99	0.94	0.82	0.78	0.98		0.92	0.58	0.95	0.56	0.99	0.71	0.56	0.97	0.59	0.64	0.98	0.5	0.87	0.93	0.89	0.97	0.09	0.5	0.64	0.78
Net Debt	0.95	0.99	0.87	0.86	0.9	0.92		0.5	0.87	0.47	0.95	0.84	0.48	0.94	0.6	0.7	0.89	0.49	0.82	0.96	0.75	0.91	0.3	0.61	0.66	0.85
Retained Earnings	0.58	0.54	0.32	0.31	0.7	0.58	0.5		0.65	0.48	0.58	0.15	0.48	0.42	-0.15	0.15	0.62	0.28	0.13	0.34	0.62	0.55	-0.11	-0.23	-0.13	0.59
Accounts Payable	0.92	0.89	0.84	0.8	0.93	0.95	0.87	0.65		0.54	0.92	0.7	0.55	0.92	0.44	0.51	0.95	0.45	0.74	0.84	0.87	0.92	0.12	0.32	0.51	0.83
Cash	0.6	0.6	0.44	0.3	0.62	0.56	0.47	0.48	0.54		0.57	0.21	1.0	0.4	0.34	0.61	0.45	0.75	0.45	0.54	0.32	0.7	-0.25	0.2	0.43	0.5
Non Current Assets Total	1.0	0.96	0.81	0.78	0.98	0.99	0.95	0.58	0.92	0.57		0.72	0.58	0.96	0.63	0.71	0.95	0.51	0.87	0.95	0.83	0.96	0.11	0.57	0.66	0.78
Non Currrent Assets Other	0.72	0.8	0.87	0.93	0.62	0.71	0.84	0.15	0.7	0.21	0.72		0.21	0.83	0.58	0.49	0.7	0.43	0.73	0.81	0.56	0.71	0.61	0.59	0.66	0.8
Cash And Short Term Investments	0.6	0.6	0.44	0.31	0.62	0.56	0.48	0.48	0.55	1.0	0.58	0.21		0.4	0.34	0.61	0.45	0.75	0.45	0.54	0.32	0.7	-0.25	0.2	0.43	0.51
Net Receivables	0.96	0.93	0.87	0.87	0.91	0.97	0.94	0.42	0.92	0.4	0.96	0.83	0.4		0.66	0.64	0.96	0.41	0.91	0.95	0.85	0.92	0.25	0.61	0.71	0.77
Common Stock Shares Outstanding	0.62	0.59	0.56	0.54	0.52	0.59	0.6	-0.15	0.44	0.34	0.63	0.58	0.34	0.66		0.84	0.49	0.48	0.86	0.74	0.35	0.59	0.18	0.94	0.97	0.34
Non Current Liabilities Total	0.71	0.73	0.55	0.45	0.63	0.64	0.7	0.15	0.51	0.61	0.71	0.49	0.61	0.64	0.84		0.53	0.55	0.75	0.78	0.35	0.69	-0.02	0.83	0.87	0.43
Inventory	0.95	0.89	0.78	0.78	0.95	0.98	0.89	0.62	0.95	0.45	0.95	0.7	0.45	0.96	0.49	0.53		0.38	0.8	0.87	0.95	0.92	0.12	0.4	0.55	0.75
Other Current Assets	0.54	0.57	0.57	0.49	0.52	0.5	0.49	0.28	0.45	0.75	0.51	0.43	0.75	0.41	0.48	0.55	0.38		0.49	0.53	0.28	0.65	0.11	0.32	0.53	0.62
Other Stockholder Equity	0.88	0.82	0.77	0.73	0.8	0.87	0.82	0.13	0.74	0.45	0.87	0.73	0.45	0.91	0.86	0.75	0.8	0.49		0.93	0.67	0.86	0.12	0.78	0.88	0.57
Total Liab	0.96	0.97	0.87	0.83	0.88	0.93	0.96	0.34	0.84	0.54	0.95	0.81	0.54	0.95	0.74	0.78	0.87	0.53	0.93		0.72	0.94	0.22	0.72	0.79	0.77
Property Plant And Equipment Gross	0.83	0.74	0.67	0.67	0.86	0.89	0.75	0.62	0.87	0.32	0.83	0.56	0.32	0.85	0.35	0.35	0.95	0.28	0.67	0.72		0.82	0.06	0.23	0.38	0.62
Total Current Assets	0.98	0.95	0.84	0.78	0.95	0.97	0.91	0.55	0.92	0.7	0.96	0.71	0.7	0.92	0.59	0.69	0.92	0.65	0.86	0.94	0.82		0.09	0.49	0.67	0.81
Short Term Debt	0.1	0.22	0.36	0.62	0.02	0.09	0.3	-0.11	0.12	-0.25	0.11	0.61	-0.25	0.25	0.18	-0.02	0.12	0.11	0.12	0.22	0.06	0.09		0.28	0.18	0.51
Intangible Assets	0.56	0.57	0.52	0.52	0.42	0.5	0.61	-0.23	0.32	0.2	0.57	0.59	0.2	0.61	0.94	0.83	0.4	0.32	0.78	0.72	0.23	0.49	0.28		0.91	0.3
Common Stock Total Equity	0.67	0.66	0.64	0.6	0.55	0.64	0.66	-0.13	0.51	0.43	0.66	0.66	0.43	0.71	0.97	0.87	0.55	0.53	0.88	0.79	0.38	0.67	0.18	0.91		0.42
Short Term Investments	0.79	0.86	0.86	0.9	0.77	0.78	0.85	0.59	0.83	0.5	0.78	0.8	0.51	0.77	0.34	0.43	0.75	0.62	0.57	0.77	0.62	0.81	0.51	0.3	0.42

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	30.8B	32.2B	32.5B	35.1B	40.4B	42.4B
Short Long Term Debt Total	9.5B	9.5B	9.3B	9.5B	10.9B	11.5B
Other Current Liab	2.9B	2.8B	2.5B	3.0B	3.4B	3.6B
Total Current Liabilities	3.7B	4.3B	3.8B	4.9B	5.7B	6.0B
Total Stockholder Equity	15.3B	16.6B	17.6B	19.3B	22.2B	23.3B
Property Plant And Equipment Net	2.5B	2.7B	2.8B	3.3B	3.8B	4.0B
Net Debt	7.8B	7.5B	8.4B	8.6B	9.9B	10.4B
Retained Earnings	(2.4B)	(1.4B)	(750M)	819M	737.1M	774.0M
Accounts Payable	513M	794M	862M	942M	1.1B	1.1B
Cash	1.7B	1.9B	928M	865M	994.8M	585.9M
Non Current Assets Total	24.1B	25.9B	26.7B	28.6B	32.9B	34.6B
Non Currrent Assets Other	545M	563M	707M	680M	782M	821.1M
Cash And Short Term Investments	1.7B	1.9B	928M	865M	994.8M	598.2M
Net Receivables	1.5B	1.8B	2.0B	2.2B	2.6B	2.7B
Common Stock Shares Outstanding	1.4B	1.4B	1.4B	1.5B	1.7B	1.2B
Liabilities And Stockholders Equity	30.8B	32.2B	32.5B	34.9B	40.1B	42.1B
Non Current Liabilities Total	11.8B	11.3B	11.1B	10.7B	12.3B	6.2B
Inventory	1.4B	1.6B	1.9B	2.5B	2.9B	3.0B
Other Current Assets	2.1B	1.0B	995M	937M	1.1B	544.2M
Other Stockholder Equity	17.5B	17.7B	18.0B	18.4B	21.2B	22.2B
Total Liab	15.5B	15.6B	14.9B	15.6B	17.9B	18.8B
Property Plant And Equipment Gross	2.5B	2.3B	2.4B	6.8B	7.8B	8.2B
Total Current Assets	6.7B	6.3B	5.8B	6.5B	7.5B	7.9B
Accumulated Other Comprehensive Income	207M	263M	269M	49M	56.4M	59.2M
Short Term Debt	13M	261M	20M	531M	610.7M	417.5M
Intangible Assets	5.9B	6.1B	5.9B	6.0B	6.9B	4.9B
Other Liab	3.0B	2.2B	2.1B	1.8B	2.1B	1.9B
Other Assets	4.6B	3M	2M	(1M)	1.2M	1.1M
Long Term Debt	9.1B	8.8B	8.9B	8.6B	9.9B	5.6B
Good Will	10.0B	12.0B	12.9B	14.4B	16.5B	8.6B
Property Plant Equipment	2.1B	2.1B	2.3B	2.8B	3.3B	1.7B
Current Deferred Revenue	138M	208M	220M	266M	239.4M	333.1M
Net Tangible Assets	(4.2B)	9.4B	(1.7B)	11.7B	13.4B	14.1B
Retained Earnings Total Equity	(2.3B)	(2.4B)	(1.4B)	(750M)	(862.5M)	(905.6M)
Long Term Debt Total	8.6B	9.1B	8.8B	8.9B	10.3B	6.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Total Assets vs Cash Analysis

Total Assets vs Cash

Total Assets vs Cash Correlation Analysis

Correlation Coefficient

Total Assets

Cash

Boston Scientific fundamental ratios Correlations

Boston Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boston Scientific fundamental ratios Accounts

Also Currently Popular

Additional Tools for Boston Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.98	Total Assets

Short Term Debt	- 0.25	Cash And Short Term Investments
Short Term Debt	- 0.25	Cash
Intangible Assets	- 0.23	Retained Earnings
Common Stock Shares Outstanding	- 0.15	Retained Earnings
Common Stock Total Equity	- 0.13	Retained Earnings
Short Term Debt	- 0.11	Retained Earnings